Udayavni Special

Malaria drug considered for COVID-19 may raise risk of heart problems, scientists say


PTI, Apr 3, 2020, 12:52 PM IST

New Delhi: The anti-malaria drug hydroxychloroquine and the antibiotic azithromycin, which are being considered by some for treating COVID-19, may increase the risk for dangerous abnormal heart rhythms, US cardiologists have warned.

The researchers from Oregon Health & Science University (OHSU) and Indiana University recommend that clinicians treating COVID-19 patients with the malaria-antibiotic drug combination should consider monitoring those patients for ventricular arrhythmia.

“The condition leads to the lower heart chambers beating quickly and irregularly, and can lead to cardiac arrest,” they said.

In a paper published in the American College of Cardiology’s Cardiology Magazine, the researchers noted that there are hundreds of drugs that can increase the risk for cardiac arrest.

However, they said that using two together in patients who are already at risk or critically ill could increase that risk further.

“While there is yet very little data regarding hydroxychloroquine and azithromycin’s effectiveness as a treatment for COVID-19, some clinicians are considering combining them during this global pandemic,” said Eric Stecker, the paper’s lead author.

“If physicians use their best medical judgment and order this drug combination for coronavirus patients, we want them to be aware of potential adverse side effects,” said Stecker, an associate professor at the OHSU School of Medicine.

The researchers recommend clinicians who treat COVID-19 patients with the drug combination also monitor patients for dangerous arrhythmias.

However, they acknowledged that limited resources could make monitoring a challenge.

“Until we have clinical outcome data supporting the benefit or harm of these medications, I would advocate for a cautious approach in using the combination of hydroxychloroquine and azithromycin,” Stecker said.

“Any medications that increase the risk of cardiac risk require consideration of both risks and benefits, and right now we do not have evidence that benefits outweigh risks for use of hydroxychloroquine or chloroquine,” he said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Terrorism threatens to engulf world in carnage similar to one witnessed during two World Wars: India

Sunny Deol tests COVID-19 positive, says Himachal Pradesh health secretary

Russia deploys missiles to Pacific islands claimed by Japan

Deep depression over Bay of Bengal now cyclonic storm ‘Burevi’

Ex-Karnataka minister Varthur Prakash abducted, later released, say police sources

K’taka COVID-19 update: 1330 new cases, 886 discharges, 14 deaths on Nov 30

Indian Navy successfully test-fires naval version of BrahMos missile



Related Articles More

Should isolation periods be shorter for people with Covid-19?

World AIDS Day 2020: Everything you need to know

India recorded largest reduction in malaria cases in South-East Asia between 2000-2019: WHO

Plastic pollution from fishing nets threatening Ganges wildlife, study finds

Some tree leaves will fall 3-6 days in advance by end of century due to climate change

MUST WATCH

Boat tragedy: Dead body of one fishermen found

Mangaluru: Six fishermen missing after boat overturns

Leaving Kannada language in the nameplate of Krishna Math : Severe objection by Kasapa

What is the importance of Ayurvedic medical system in treating diseases?

Success story of a couple In Agriculture | Integrated Farming

Latest Additions

Mangaluru boat tragedy: Fishermen declare bandh until all missing fishermen found

England romps to 3-0 T20 series win over South Africa

Terrorism threatens to engulf world in carnage similar to one witnessed during two World Wars: India

Sunny Deol tests COVID-19 positive, says Himachal Pradesh health secretary

‘Indian-American Neera Tanden a brilliant policy mind with critical practical experience across govts’

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.